Agency Information Collection Request: 60-Day Public Comment Request, 35812-35813 [2021-14436]
Download as PDF
<![CDATA[
35812
Federal Register / Vol. 86, No. 127 / Wednesday, July 7, 2021 / Notices
described in FDA’s March 2020
Enforcement Policy for Ventilators
and Accessories and Other
Respiratory Devices During the
Coronavirus Disease 2019 (COVID–
19) Public Health Emergency
located at https://www.fda.gov/
media/136318/ download.
17. Alcohol-based (over 60 percent)
hand sanitizer and rubs.
Notice of Designation of Scarce
Materials or Threatened Materials
Health or medical resources, or any of
their essential components, determined
by the Secretary of HHS to be needed to
respond to the spread of COVID–19 and
which are, or are likely to be, in short
supply (scarce materials) or the supply
of which would be threatened by
hoarding (threatened materials).
Designated scarce materials or
threatened materials are subject to
periodic review by the Secretary.
The following materials are
designated, pursuant to section 102 of
the Defense Production Act (50 U.S.C.
4512) and Executive Order 13190 of
March 23, 2020 (Preventing Hoarding of
Health and Medical Resources to
Respond to the Spread of COVID–19), as
scarce materials or threatened materials:
1. Medical gowns or apparel, e.g.,
surgical gowns or isolation gowns
2. Laboratory reagents and materials
used for isolation of viral genetic
material and testing, such as transport
media, collection swabs, test kits and
reagents specific to those kits, and
consumables such as plastic pipette tips
and plastic tubes
3. Drug products currently
recommended by the National Institutes
of Health COVID–19 Treatment
Guidelines Panel, including (as of April
21, 2021) remdesivir and
dexamethasone
4. Syringes and hypodermic needles
(whether distributed separately or
attached together) generally used in the
United States for vaccinations that are
either:
(i) Piston syringes in 1 ml or 3 ml
sizes that allow for the controlled and
precise flow of liquid as described by 21
CFR 880.5860, that are compliant with
ISO 7886–1:2017 and use only Current
Good Manufacturing Practices (CGMP)
processes; or
(ii) Hypodermic single lumen needles
between 1’’ and 1.5’’ and 22 to 25 gauge
between 1’’ and 1.5’’ and 22 to 25 gauge
that have engineered sharps injury
protections as described in the
Needlestick Safety and Prevention Act,
Public Law 106–430, 114 Stat. 1901
(Nov. 6, 2000) and OSHA standard 29
CFR 1910.1030, Bloodborne Pathogens.’’
Authority: The authority for this Notice is
Executive Order 13910 and section 102 of the
Defense Production Act of 1950, 50 U.S.C.
4512, as amended.
Dated: June 30, 2021.
Xavier Becerra
Secretary, Department of Health and Human
Services.
[FR Doc. 2021–14383 Filed 7–2–21; 4:15 pm]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–4040–0001]
Agency Information Collection
Request: 60-Day Public Comment
Request
Office of the Secretary, Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before September 7,
2021.
SUMMARY:
Submit your comments
sagal.musa@hhs.gov or by calling (202)
205–2634.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 4040–0001–
Revision–60D and project title for
reference, to Sagal Musa, email:
sagal.musa@hhs.gov, or call (202) 205–
2634 the Reports Clearance Officer.
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: SBIR/STTR
Information.
Type of Collection: Revision of A
Currently Approved Collection.
OMB No.: 4040–0001.
Abstract: The SBIR (Small Business
Innovation Research)/STTR (Small
Business Technology Transfer) program
is designed to stimulate technological
innovation in the private sector by
strengthening the role of small business,
increasing the commercial application
of federally supported research results,
as well as fostering and encouraging
participation by socially and
economically disadvantaged and
women-owned small businesses. This
form is used by grant applicants to
apply for SBIR/STTR-related grants.
Grants.gov seeks to include a question
regarding the use of SBIR/STTR funds
for Technical and Business Assistance
(TABA).
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
ANNUALIZED BURDEN HOUR TABLE
Average
burden per
response
Respondents
(If necessary)
SBIR/STTR Information ....................
Grant Applicants ...............................
6,376
1
1
6,376
Total ...........................................
...........................................................
6,376
1
1
6,376
VerDate Sep<11>2014
17:44 Jul 06, 2021
Jkt 253001
PO 00000
Frm 00084
Fmt 4703
Number of
respondents
Number of
responses per
respondents
Forms
(If necessary)
Sfmt 4703
E:\FR\FM\07JYN1.SGM
07JYN1
Total
burden hours
Federal Register / Vol. 86, No. 127 / Wednesday, July 7, 2021 / Notices
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–14436 Filed 7–6–21; 8:45 am]
BILLING CODE 4151–AE–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Charter Renewal
In accordance with Title 42 of the
U.S. Code of Federal Regulations,
Section 217a, notice is hereby given that
the Charter for the Sickle Cell Diseases
Advisory Committee was renewed for
an additional two-year period on June
30, 2021.
It is determined that the Sickle Cell
Diseases Advisory Committee is in the
public interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory. Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), Telephone (301)
496–2123, or harriscl@mail.nih.gov.
Dated: June 30, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–14420 Filed 7–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:44 Jul 06, 2021
Jkt 253001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Conference Grants.
Date: August 4, 2021.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Michael P. Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–Z,
Bethesda, MD 20892, (301) 827–7975,
reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 30, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–14421 Filed 7–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director Notice of Charter
Renewal
In accordance with Title 42 of the
U.S. Code of Federal Regulations,
Section 217a, notice is hereby given that
the Charter for the Novel and
Exceptional Technology and Research
Advisory Committee was renewed for
an additional two-year period on June
30, 2021.
It is determined that the Novel and
Exceptional Technology and Research
Advisory Committee is in the public
interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), Telephone (301)
496–2123, or harriscl@mail.nih.gov.
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
35813
Dated: June 30, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–14368 Filed 7–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis/Chronic Fatigue
Syndrome.
Date: July 30, 2021.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, (301) 435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–21–
089 SPF Macaque Colonies.
Date: August 6, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\07JYN1.SGM
07JYN1
]]>Agencies
[Federal Register Volume 86, Number 127 (Wednesday, July 7, 2021)]
[Notices]
[Pages 35812-35813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-4040-0001]
Agency Information Collection Request: 60-Day Public Comment
Request
AGENCY: Office of the Secretary, Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before September 7,
2021.
ADDRESSES: Submit your comments [email protected] or by calling (202)
205-2634.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 4040-0001-Revision-
60D and project title for reference, to Sagal Musa, email:
[email protected], or call (202) 205-2634 the Reports Clearance
Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: SBIR/STTR Information.
Type of Collection: Revision of A Currently Approved Collection.
OMB No.: 4040-0001.
Abstract: The SBIR (Small Business Innovation Research)/STTR (Small
Business Technology Transfer) program is designed to stimulate
technological innovation in the private sector by strengthening the
role of small business, increasing the commercial application of
federally supported research results, as well as fostering and
encouraging participation by socially and economically disadvantaged
and women-owned small businesses. This form is used by grant applicants
to apply for SBIR/STTR-related grants. Grants.gov seeks to include a
question regarding the use of SBIR/STTR funds for Technical and
Business Assistance (TABA).
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number of
Forms (If necessary) Respondents (If Number of responses per Average burden Total burden
necessary) respondents respondents per response hours
----------------------------------------------------------------------------------------------------------------
SBIR/STTR Information......... Grant Applicants 6,376 1 1 6,376
---------------------------------------------------------------
Total..................... ................ 6,376 1 1 6,376
----------------------------------------------------------------------------------------------------------------
[[Page 35813]]
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2021-14436 Filed 7-6-21; 8:45 am]
BILLING CODE 4151-AE-P
